|
|
|
Luoyang Huizhong Animal-medicine Co. Ltd
|
|
| |
| 6. Vaccines |
|
 |
Newcastle Disease (La Sota), Infectious Bronchitis (M41), and Avian Influenza (H9, HL) United Inactivated Vaccine |
|
|
|
|
|
 Click to enlarge image
|
The Characteristics of the Newcastle Disease (La Sota), Infectious Bronchitis (M41), and Avian Influenza (H9, HL) united inactivated Vaccine.
As the same immune program in three epidemic poultry disease, such as Newcastle Disease, Infectious Bronchitis, and Avian Influenza, it is possible to make a united vaccine together in order to utilize more practical, more economic, and more convenient. Three viruses were isolated from clinic and laboratory in Newcastle Disease, Infectious Bronchitis, and Avian Influenza, respectively. The advanced united inactivated vaccine involves three strains of each unique La Sota strain NDV, M41 strain IBV, and H9N2, HL epidemic strain AIV.
The characteristics of the Newcastle Disease (La Sota), Infectious Bronchitis (M41), and Avian Influenza (H9, HL) united inactivated Vaccine is as bellows:
1, The Newcastle Disease (La Sota), Infectious Bronchitis (M41), and Avian Influenza (H9, HL) united inactivated Vaccine is the first, the unique, contained H9 strain AIV inactivated united vaccine, and was authorized by the Agricultural Ministry of China (AMC). Its documentation registered number of approval is [vet, pharm, vaccine (2006)160022124].
2, The related researches, application to the AMC, and manufacture were taken by the LuoYang Pulike Bioengineering Company Limited itself. Company owns the intellectual property right, and all right were reserved.
3, The innovation was greatly wide appreciated, and the patent number in China is 200610048498.4.
4, The avian influenza virus was isolated from wild, which is the special HL strain that was identify by the China National Avian Influenza reference laboratory. It contains widely antigen spectrum, and good immune response.
5, The antigen concentration equipment was imported from Millipore products, USA. The vaccine antigens were highly concentrated more than the national requirement to ensure each strain contains the same highly titer, so that could stimulate birds to produce antibody higher titer and longer period of time for protection from the wild challenge.
6, The standard to detect and to determine of the infectious bronchitis virus is matched the international standard, and this standard was approval by the AMC, moreover, was recommended as a national standard use as for determination of vaccine contained IBV of the applicants.
7, The adjuvant is using a French company, which could be Freud completed adjuvant to stimulate bird produce Th1 cells. The antibody will be produced faster, more persistent, and other advantage are less stress, less residue, and less sticky so that it is more safety, more efficient and easier to inject.
8, The standard for manufacture program is Europe standard (PH.ERO.RD.2000). The quality of each batch products reach to the international standard.
9, The advantage is also involving injection once to prevent three epidemic poultry diseases. It could save money, save labors and more easy to make the entire immune program.
|
|
|
|
| |
|
|
|
Related Keywords:
Bookmark / Share this page